HomeMAZE • NASDAQ
add
Maze Therapeutics Inc
Previous close
$33.22
Day range
$32.33 - $33.91
Year range
$6.72 - $34.29
Market cap
1.44B USD
Avg Volume
472.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 36.47M | 43.34% |
Net income | -33.68M | -124.22% |
Net profit margin | — | — |
Earnings per share | -0.77 | — |
EBITDA | -35.82M | -125.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 264.54M | 51.11% |
Total assets | 303.52M | 40.65% |
Total liabilities | 41.28M | -56.21% |
Total equity | 262.24M | — |
Shares outstanding | 43.85M | — |
Price to book | 5.56 | — |
Return on assets | -28.66% | — |
Return on capital | -30.14% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -33.68M | -124.22% |
Cash from operations | -30.05M | -120.72% |
Cash from investing | -393.00K | -145.62% |
Cash from financing | 612.00K | 297.40% |
Net change in cash | -29.83M | -120.57% |
Free cash flow | -19.34M | — |
About
Founded
2017
Headquarters
Website
Employees
125
